跳至主要内容
临床试验/EUCTR2008-000333-22-GB
EUCTR2008-000333-22-GB
进行中(未招募)
不适用

A study to compare the effects on stratum corneum of two medical hand wash formulations, using non-invasive instrumental methods in human volunteers.

Dermal Laboratories Ltd0 个研究点目标入组 40 人2008年11月19日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
The study is a healthy volunteer study.
发起方
Dermal Laboratories Ltd
入组人数
40
状态
进行中(未招募)
最后更新
13年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2008年11月19日
结束日期
待定
最后更新
13年前
研究类型
Interventional clinical trial of medicinal product
性别
All

研究者

入排标准

入选标准

  • Forty male and female volunteers shall be recruited. The volunteers shall be healthy adults, aged 18 to 65 years. Written informed consent must be obtained from volunteers who are to take part in the study.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range

排除标准

  • 1\. Females who are pregnant or lactating (although it is generally considered inappropriate for this group to take part in trials, there are no safety concerns regarding the use of either product in these groups)
  • 2\. History of skin disease or allergy relevant to the study
  • 3\. Subjects who have known allergies to the test products or their ingredients
  • 4\. Use of any topical or systemic medication or drug likely to affect skin response
  • 5\. Any significant visible skin abnormality or excessive hair growth at the test measurement sites
  • 6\. Participation in an irritation test, on the same skin site, in the past month, or a sensitisation test, on any skin site, during the past 3 months
  • 7\. Concurrent participation in any other safety test
  • 8\. Any irritation, tattoos, scars or birthmarks at the test sites
  • 9\. Employees of RSSL Pharma or Dermal Laboratories, or an immediate family member (partner, offspring, parents, siblings or sibling’s offspring) of an employee.
  • 10\. Any other medical condition which in the judgment of the Investigator would put the subject at unacceptable risk for participation in the study.

结局指标

主要结局

未指定

相似试验